Join us for a video introduction to HEMLIBRA, a new treatment option for adults and children who have hemophilia A with factor VIII inhibitors. In this webcast, we’ll talk about several important topics:

  • The most important facts you should know about HEMLIBRA, including information regarding the use of a bypassing agent when using HEMLIBRA
  • Information about serious and common side effects
  • Details on how HEMLIBRA is thought to work
  • An overview of the HEMLIBRA clinical studies
Register to watch the HEMLIBRA webcast.

Financial Support

Services that may help you access HEMLIBRA

Connects Patient Resource Center

HEMLIBRA support and resources